FOXO3 and cancer: Although no statistically significant differences were detected in the number of FOXO3-expressing primordial follicles between both groups (see Fig. 4), samples from anti-cancer treated patients showed a tendency to have more primordial follicles positive for nuclear FOXO3 and less cytoplasmic pFOXO3.